DrugPatentWatch Database Preview

Helsinn Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for HELSINN HLTHCARE, and when can generic versions of HELSINN HLTHCARE drugs launch?

HELSINN HLTHCARE has four approved drugs.

There are twenty-five US patents protecting HELSINN HLTHCARE drugs.

There are two hundred and thirty-nine patent family members on HELSINN HLTHCARE drugs in sixty-seven countries and fourteen supplementary protection certificates in ten countries.

Summary for Helsinn Hlthcare

International Patents:	239
US Patents:	25
Tradenames:	2
Ingredients:	3
NDAs:	4

Drugs and US Patents for Helsinn Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Helsinn Hlthcare	AKYNZEO	fosnetupitant chloride hydrochloride; palonosetron hydrochloride	POWDER;INTRAVENOUS	210493-001	Apr 19, 2018		RX	Yes	Yes	10,208,073
Helsinn Hlthcare	ALOXI	palonosetron hydrochloride	INJECTABLE;INTRAVENOUS	021372-001	Jul 25, 2003	AP	RX	Yes	Yes	9,125,905*PED				Y
Helsinn Hlthcare	ALOXI	palonosetron hydrochloride	INJECTABLE;INTRAVENOUS	021372-002	Feb 29, 2008	AP	RX	Yes	Yes	8,518,981*PED				Y
Helsinn Hlthcare	AKYNZEO	netupitant; palonosetron hydrochloride	CAPSULE;ORAL	205718-001	Oct 10, 2014		RX	Yes	Yes	9,951,016		Y	Y

Expired US Patents for Helsinn Hlthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Helsinn Hlthcare	ALOXI	palonosetron hydrochloride	CAPSULE;ORAL	022233-001	Aug 22, 2008	5,202,333
Helsinn Hlthcare	AKYNZEO	netupitant; palonosetron hydrochloride	CAPSULE;ORAL	205718-001	Oct 10, 2014	5,202,333
Helsinn Hlthcare	ALOXI	palonosetron hydrochloride	INJECTABLE;INTRAVENOUS	021372-002	Feb 29, 2008	5,202,333*PED
Helsinn Hlthcare	ALOXI	palonosetron hydrochloride	INJECTABLE;INTRAVENOUS	021372-001	Jul 25, 2003	5,202,333*PED

International Patents for Helsinn Hlthcare Drugs

Country	Patent Number	Estimated Expiration
Portugal	2361090
Slovenia	2361090
China	104856998
Poland	2722044

Supplementary Protection Certificates for Helsinn Hlthcare Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1035115	C01035115/01	Switzerland		PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: SWISSMEDIC 65499 06.11.2015
1035115	1590040-0	Sweden		PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150529
1035115	PA2015036,C1035115	Lithuania		PRODUCT NAME: NETUPITANTAS; REGISTRATION NO/DATE: EU/1/15/1001 20150527
0430190	18/2005	Austria		PRODUCT NAME: PALONOSETRON, DESSEN SALZE UND STEREOISOMERE; REGISTRATION NO/DATE: EU/1/04/306/001 20050322

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Helsinn
• Helsinn Hlthcare